At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...

Scale becomes manageable when generative AI is treated as a service with explicit constraints and measurable outcomes. Rely ...

A surge in real-world attacks against agentic AI systems is reshaping how we think about risk. Based on 12 months of red ...

A new study discovers a non-repeating genomic master clock led by MYRF-1 and LIN-42 that drives cellular development.

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 05 4 June 2026 Worldwide ...